# Clinical Development and Labeling of Anti-Infective Drug Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/clinical-development-and-labeling-of-anti-infective-drug-products/67f316ae-b6a3-4be9-9f04-f8ca70727735

> FDA guidance document: Clinical Development and Labeling of Anti-Infective Drug Products. Issue date: February 12, 2001. Get complete insights and analysis.

---

## Details

- Title: Clinical Development and Labeling of Anti-Infective Drug Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-02-12
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/None found">None found</a>

## Related Documents

- [Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-human-pharmacokinetics-and-bioavailability-section-of-an-application/0fc0547b-5081-4033-af56-10b885a39a8f)
- [Preparation of Investigational New Drug Products (Human and Animal):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preparation-of-investigational-new-drug-products-human-and-animal-guidance-for-industry/4382914f-5b98-4ad4-91c1-ed6e2893e213)
- [Format and Content of the Nonclinical Pharmacology/Toxicology Section of an Application*:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-nonclinical-pharmacologytoxicology-section-of-an-application-guidance-for-industry/4c2b4b0e-2182-43a9-b9b0-c3c92aee26b9)